Review Article: Heart Rate and Blood Pressure Control in Vasovagal Syncope

Journal of Interventional Cardiac Electrophysiology

Volumn 2, Issue 1, 1997, Pages 25-32

  Benditt, David G ^a   Fabian, William ^a   Iskos, Demos ^a   Lurie, Keith G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bradycardia; Hypotension; Syncope; Vasovagal

Indexed keywords

EID: 2342529959     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009756521965     Document Type: Review

References (68)

1. Lewis T. Vasovagal syncope and the carotid sinus mechanism. With comments on Gower's and Nothnagel's syndrome. Br Med J 1932;1:873-876.
2. van Lieshout JJ, Wieling W, Karemaker JM, Eckberg DL. The vasovagal response. Clin Sci 1991;81:575-686.
3. Benditt DG, Sakaguchi S, Schultz JJ, Remole S, Adler S, Lurie KG. Syncope. Diagnostic considerations and the role of tilt table testing. Cardiol Rev 1993;1:146-156.
4. Kosinski D, Grubb B, Temesy-Armos P. Pathophysiological aspects of neurocardiogenic syncope: current concepts and new perspectives. PACE 1995;18:716-724.
5. Njemanze PC. Critical limits of pressure-flow relation in the human brain. Stroke 1992; 23:1743-1747.
6. Diehl RR, Linden D, Chalkiadaki, Bernd Ringelstein E, Berlit P. Transcranial Doppler during neurocardiogenic syncope. Clin Autonom Res 1996;6:71-74.
7. Grubb BP, Gerard G, Roush K, Temesy-Armos P, Montford P, Elliott L, Hahn H, Brewster P. Cerebral vasoconstriction during head-upright tilt-induced vasovagal syncope. Circulation 1991;84:1157-1164.
8. Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG. Vasovagal syncope after infusion of a vasodilator in a heart transplant recipient. New Engl J Med 1990;332(Questioned equal to)2-604.
9. Fitzpatrick AP, Banner N, Cheng A, Yocoub M, Sutton R. Vasovagal syncope may occur after orthotopic heart transplantation. J Am Coll Cardiol 1993;21:1132-1137.
10. Weiss S, Baker JP. The carotid sinus reflex in health and disease. Its role in the causation of fainting and convulsions. Medicine 1933;12:297-354.
11. Almquist A, Gornick CC, Benson DW Jr, Dunnigan A, Benditt DG. Carotid sinus hypersensitivity: evaluation of the vasodepressor component. Circulation 1985;67:927-936.
12. Tea SH, Mansourati J, L'Heveder G, Mabin D, Blanc J-J. New insights into the pathophysiology of carotid sinus syndrome. Circulation 1996;93:1411-1416.
13. Pelletier CL, Shephered JT. Circulatory reflexes from mechanoreceptors in the cardioaortic area. Circ Res 1973;33: 131-138.
14. Abboud F. Neurocardiogenic syncope. N Engl J Med 1993; 328:1117-1120.
15. Rea R, Thames MD. Nueral control mechanisms and vasovagal syncope. J Cardiovasc Electrophysiol 1993;4:587-595.
16. Adler PSJ, France C, Ditto B. Baroreflex sensitivity at rest and during stress in individuals with a history of vasovagal syncope. J Psychsomat Res 1991;35:591-597.
17. Lippman IN, Stein KM, Lerman BB. Failure to decrease parasympathetic tone during upright tilt predict a positive tilt-table test. Am J Cardiol 1995;75:591-595.
18. Baharav A, Mimouni M, Lehrman-Sagie T, Izraeli S, Akslrod S. Spectral analysis of heart rate in vasovagal syncope: the automatic nervous system in vasovagal syncope. Clin Autonom Res 1993;3:261-269.
19. Eckberg DL, Abboud FM, Mark AL. Modulation of carotid baroreceptor responsiveness in man:effects of posture and propranol. J Appl Physiol 1976;41:383-387.
20. Simone F. Vegetative nervous system and syncopes. Functional Neurol 1990;5:187-192.
21. Benarroch EE. The central autonomic network. Functional organization, dysfunction, and perspective. Mayo Clin Proc 1993;68:988-1001.
22. Mancia G, Donald DE. Demonstration that atria, ventricles, and lung each are responsible for a tonic inhibition of the vasomotor center in the dog. Circ Res 1975;36:310-318.
23. Pawelczyk JA, Raven PB. Reductions in central venous pressure improve carotid baroreflex responses in concious men. Am J Physiol 1989;257:H1389-1395.
24. Victor RG, Mark AL. Interaction of cardiopulmonary and carotid baroreflex control of vascular resistance in humans. J Clin Invest 1985;76:1592-1598.
25. Perna GP, Ficola U, Salvatori MP, Stanislao M, Vigna C, Villella A, Russo A, Fernelli R Vittori PGP, Loperfido F. Increase of plasma beta endorphins in vasodepressor syncope. Am J Cardiol 1990;65:929-930.
26. Faden AI, Jacobs TP, Holaday JW. Opiate antagonist improves neurologic recovery after spinal injury. Science 1981; 211:493-494.
27. Rutter PC, Potocnik SJ, Ludbrook J. Sympathoadrenal mechanisms in cardiovascular responses to naloxone after hemorrhage. Am J Physiol 1987;252:H40-H46.
28. Evans RG, Ludbrook J, Potocnik SJ. Intracisternal naloxone and cardiac nerve blockade prevent vasodilatation during simulated hemorrhage in awake rabbits. J Physiol (London) 1989;409:1-14.
29. Smith ML, Carlson MD, Thames MC. Naloxone does not prevent vasovagal syncope during simulated orthostasis in humans. J Autonom Nervous System 1993;45:1-9.
30. Kosinski D, Grubb BP, Temesy-Armos P. The use of serotonin reuptake inhibitors in the treatment of neurally mediated cardiovascular disorders. J Serotonin Res 1994;1:85-90.
31. Kosinski D, Grubb BP. Neurally mediated syncope with an update on indications and usefulness of head-up tilt table testing and pharmacologie therapy. Curr Opinion in Cardiol 1994;9:53.
32. G-Methyl-L-Arginine, an inhibitor of L-Arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo: a role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992;70:607-611.
33. Kaufmann H, Berman J, Oribe E, et al. Possible increases in EDRF/NO in neurally mediated syncope (Abstract). Clin Autonom Res 1993;3:69.
34. Dietz NM, Rivera JM, Eggener SE, Fix RT, Warner DO, Joyner MJ. Nitric oxide contributes to the rise in forearm blood flow during mental stress in humans. J Physiol (London) 1994;480:361-368.
35. Dietz NM, Joyner MJ, Shepherd JT. Vasovagal syncope and skeletal muscle vasodilatation. The continuing conundrum. PACE (Supp) 1997, in press.
36. Sander-Jensen K, Secher NH, Astrup A, Christensen NJ, Giese J, Schwartz TW, Warberg J, Bie P. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 1986;251:R742-R748.
37. Fitzpatrick A, Williams T, Jeffrey C, Lightman S, Sutton R. Pathogenic role for arginine vasopressin (AVP) and catecholamines (EP & NEP) in vasovagal syncope (Abstract). JACC 1990;15:98.
38. Thames MD, Schmid PG. Cardiopulmonary receptors with vagal afferents tonically inhibit ADH release in the dog. Am J Physiol 1979;237(3):H299-H304.
39. Beiser GD, Zelis R, Epstein SE, Mason DT, Braunwald E. The role of skin and muscle resistance vessels in reflexes mediated by the baroreceptor system. J Clin Invest 1970;49:225-231.
40. Wallin BG, Sundlof, G. Sympathetic outflow in muscles during vasovagal syncope. J Autonom Nerv Syst 1982;6: 287-291.
41. Goldstein DS, Spanarkel M, Pitterman A, Toltzis R, Gratz E, Epstein S, Keiser HR. Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982;104:1071-1075.
42. Perry JC, Garson A Jr. The child with recurrent syncope: autonomic function testing and beta-adrenergic hypersensitivity. J Am Coll Cardiol 1991;17:1168-1171.
43. Vingerhoets AJJM. Biochemical changes in two subjects succumbing to syncope. Psychosom Med 1984;46:95-103.
44. Schlesinger Z. Life-threatening "vagal reaction" to physical fitness test. JAMA 1973;226(9):1119 (letter).
45. Chosy JJ, Graham DT. Catecholamines in vasovagal fainting. J Psychosom Res 1965;9:1891-1894.
46. Sander-Jensen K, Secher NH, Astrup A, Christensen NJ, Giese J, Schwartz TW, Warberg J, Bie P. Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 1986;251:R742-R748.
47. Abi-Samra F, Maloney JD, Fouad-Tarazi FM, Castle L. The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin. PACE 1988;11:1202-1214.
48. Remole SC, Neustel M, Bailin S, Chen M-Y, Milstein S, Benditt DG. Adrenal effluent may account for increased norepinephrine levels during tilt-induced syncope (Abstract). Circulation (Supp II) 1991;84:233.
49. Muscholl E. Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Amer J Physiol 1980; 239:H713-720.
50. Levy MN. Cardiac sympathetic-parasympathetic interactions. Fed Proc 1984;43:2598-2602.
51. Potter EK. Prolonged non-adrenergic inhibition of cardiac vagal action by sympathetic stimulation: neuromodulation by neuropeptide-Y. Neuroscience Letters 1985;54:117-121.
52. Potter EK. Presynaptic inhibition of cardiac vagal postganglionic nerves by neuropeptide-Y. Neuroscience Letters 1987:83:101-106.
53. Warner MR, Levy MN. Inhibition of cardiac vagal effects by neurally released and exogenous neuropeptide Y. Circ Res 1989;65:1536-1546.
54. Revington ML, McCloskey DI. Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs. J Physiol (London) 1990;428: 359-370.
55. Donald DE, Shepherd JT. Reflexes from the heart and lungs: physiological curiosities or important regulatory mechanisms. Cardiovasc Res 1978;12:449-469.
56. Abboud FM, Thames MD. Interaction of cardiovascular reflexes in -circulatory control. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology. Section 2: The Cardiovascular System. Peripheral Circulation and Organ Blood Flow. American Physiological Society, Bethesda, 1983; 675-753.
57. Blair DA, Glover WE, Greenfield ADM, Roddie IC. Excitation of cholinergic vasodilator nerves to human skeletal muscles during emotional stress. J Physiol (London) 1959;148: 633-647.
58. Brody MJ. Histaminergic and cholinergic vasodilator systems. In: Vanhoutte PM, Leusen I, eds. Mechanisms of Vasodilatation. Basel: S Karger AG, 1978; 266-277.
59. Bevan JA, Brayden JE. Nonadrenergic neural vasodilator mechanisms. Circ Res 1987;60:309-326.
60. Kellogg DL, Johnson JM, Kosiba WA. Baroreflex control of the cutaneous active vasodilator system in humans. Circ Res 1990; 66:1420-1426.
61. Burnstock G. Purinergic nerves. Pharmacol Rev 1972;24: 509-581.
62. Benditt DG, Chen M-Y, Hansen R, Buetikofer J, Lurie KG. Characterization of subcutaneous microvascular blood flow during tilt-table-induced neurally-mediated syncope. J Am Coll Cardiol 1995;25:70-75.
63. Raviele A. Gasparini G, Di Pede F, Delise P, Bonso A, Piccolo E. Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 1990;65:1322-1327.
64. Fitzpatrick A, Theodroakis G, Vardas P, Sutton R. Methdology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991;17:125-130.
65. Barron SA, Rogovski Z, Hemli Y. Vagal Cardiovascular reflexes in young persons with syncope. Ann Int Med 1993; 118:943-946.
66. Morillo CA, Klein GJ, Jones DL, Yee R. Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope. Am J Cardiol 1994;74:1258-1262.
67. Giller CA, Levine BD, Meyer Y, Buckey JC, Lane LD, Borchers DJ. Cerebral hemodynamics of normotensive hypovolemia during lower body negative pressure. J Neurosurg 1992;76:961-966.
68. Levine BD, Giller CA, Lane LD, Buckey JC, Blomqvist CG. Cerebral versus systemic hemodynamics during graded orthostatic stress in humans. Circulation 1994;90:298-306.